News & Updates
Filter by Specialty:
GLP-1 RA, with or without SGLT2 inhibitors, prevents cardiac events in T2D
Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1 RA) albiglutide results in fewer cardiovascular events, irrespective of sodium-glucose cotransporter-2 (SGLT2) inhibitor use, among patients with type 2 diabetes (T2D) and cardiovascular disease, according to the post hoc analysis of Harmony Outcomes*.
GLP-1 RA, with or without SGLT2 inhibitors, prevents cardiac events in T2D
08 Aug 2023Frequent nut intake delays cognitive decline in older adults
Eating nuts on a regular basis provides neuroprotective benefits to older adults who are overweight or obese, have metabolic syndrome, and are predisposed to memory loss or confusion, results of a cohort study have shown.
Frequent nut intake delays cognitive decline in older adults
08 Aug 2023Comorbid depression and sleep behaviour disorder puts patients and relatives at risk of neurodegeneration
Comorbid major depressive disorder and rapid eye movement sleep behaviour disorder (MDD-RBD) is a common subtype of MDD. These patients and their first-degree relatives (FDRs) are at risk of neurodegeneration, researchers from the Chinese University of Hong Kong (CUHK) have reported.
Comorbid depression and sleep behaviour disorder puts patients and relatives at risk of neurodegeneration
08 Aug 2023New independent advocacy group DPAM unites experts in combating dengue
Dengue Prevention Advocacy Malaysia (DPAM), a newly launched independent advocacy group comprising non-governmental medical and community organizations, aims to synergize efforts in supporting the Ministry of Health Malaysia (MOH) for enhanced dengue prevention, management, and control.
New independent advocacy group DPAM unites experts in combating dengue
08 Aug 2023Can a personalized diet improve glycaemic variability, HbA1c in prediabetic adults?
Adherence to a personalized calorie-restricted, weight-loss diet falls short of reducing glycaemic variability (GV) or glycated haemoglobin (HbA1c) relative to a one-size-fits-all low-fat (standardized) diet among patients with prediabetes and moderately controlled type 2 diabetes, a study has shown.